Lindane

Lindane

SCHEMBL1016220

Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl.O=P(O)(O)F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

823298382338688239847Rdl1Rdl2Rdl3

The experimentally established mechanism targets of Lindane. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.39
CYP3A4 P08684 1/20 0.39
GABRA1 P14867 1/20 0.39
GABRB1 P18505 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRR1 P24046 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA6 Q16445 1/20 0.39
CA2 P00918 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lindane SCHEMBL4354321 0.96 LMNA (0.36) LMNACYP3A4GABRA1GABRB1GABRG2
Lindane SCHEMBL333037 0.96 LMNA (0.36) LMNACYP3A4GABRA1GABRB1GABRG2
Lindane SCHEMBL2579810 0.96 LMNA (0.36) LMNACYP3A4GABRA1GABRB1GABRG2
Lindane SCHEMBL28684263 0.84 LMNA (0.46) LMNACYP3A4GABRA1GABRB1GABRG2
Lindane SCHEMBL555867 0.84 LMNA (0.46) LMNACYP3A4GABRA1GABRB1GABRG2
Lindane SCHEMBL28681567 0.84 LMNA (0.46) LMNACYP3A4GABRA1GABRB1GABRG2
Lindane SCHEMBL4515334 0.83
Lindane SCHEMBL15641482 0.80 LMNA (0.42) LMNACYP3A4GABRA1GABRB1GABRG2
Lindane SCHEMBL2580519 0.80 LMNA (0.42) LMNACYP3A4GABRA1GABRB1GABRG2
SCHEMBL634685 0.78 CA2 (0.46) LMNACA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2943466-A1 NOVEL SYNTHESIS INTERMEDIATES FOR OBTAINING DERIVATIVES OF SPHINGOSINES, CERAMIDES AND SPHINGOMYELINS WITH GOOD YIELDS M2I DEVELOPMENT (FR) 2015-11-18 EP claimed
WO-2014108564-A1 NOVEL SYNTHESIS INTERMEDIATES FOR OBTAINING DERIVATIVES OF SPHINGOSINES, CERAMIDES AND SPHINGOMYELINS WITH GOOD YIELDS M2I DEVELOPMENT (FR) 2014-07-17 WO claimed
US-20090107851-A1 Electrolytic polishing method of substrate EBARA CORPORATION (JP) 2009-04-30 US claimed
EP-3643694-B1 METHOD FOR PRODUCING BUTADIENE COMPOUND DAIKIN IND LTD (JP) 2023-11-15 EP disclosed
WO-2023063301-A1 METHOD FOR PRODUCING FLUORINATED AROMATIC COMPOUND ダイキン工業株式会社 2023-04-20 WO disclosed
WO-2023282261-A1 LAMINATE, SIGHT LINE TRACKING SYSTEM, AND HEAD-MOUNTED DISPLAY 富士フイルム株式会社 2023-01-12 WO disclosed
EP-4090651-A1 FUNGICIDAL AMIDES FMC CORPORATION (US) 2022-11-23 EP disclosed
WO-2022210595-A1 POLYMERIZABLE COMPOSITION, PHOTOCURABLE ADHESIVE AGENT, CURED PRODUCT MANUFACTURING METHOD, AND CURED PRODUCT 株式会社ADEKA 2022-10-06 WO disclosed
WO-2022152274-A1 FGFR INHIBITOR COMPOUND AND USE THEREOF 深圳康溯医药科技有限公司 2022-07-21 WO disclosed
WO-2021125021-A1 COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT 株式会社ADEKA 2021-06-24 WO disclosed
EP-3643694-A1 METHOD FOR PRODUCING BUTADIENE COMPOUND Daikin Industries, Ltd. (JP) 2020-04-29 EP disclosed
US-20040077835-A1 Chemokine receptor modulators, production and use AMYLIN PHARMACEUTICALS, INC. 2004-04-22 US disclosed
US-6664022-B1 Forming relief image on substrate by coating with amplified positive resin and iodinium or sulfonium compound comprising naphthyl, thienyl or pentafluorophenyl substituents; exposure to patterned activating radiation; development SHIPLEY COMPANY, L.L.C. 2003-12-16 US disclosed
EP-0361506-A2 Crosslinkable composition of fluorine-containing elastomer DAIKIN INDUSTRIES, LIMITED (JP) 1990-04-04 EP disclosed
EP-0291761-A2 Terminally unsaturated macromolecular monomers of polylactones and copolymers thereof THE B.F. GOODRICH COMPANY (US) 1988-11-23 EP disclosed
US-4472494-A MALEIC ANHYDRIDE-STYRENE COPOLYMER, PHOTORESIST NAPP SYSTEMS (USA), INC. (US) 1984-09-18 US disclosed
EP-0049577-B1 ALPHA-CYANOPHENOXYBENZYLAMINE DERIVATIVES, PROCESSES FOR PREPARING THEM, AND THEIR USE AS INTERMEDIATES FOR THE PREPARATION OF PYRETHROID INSECTICIDES ICI AUSTRALIA LIMITED (AU) 1984-04-11 EP disclosed
US-4420614-A CHEMICAL INTERMEDIATES, PYRETHROIDS ICI AUSTRALIA LIMITED (AU) 1983-12-13 US disclosed
EP-0049577-A1 Alpha-cyanophenoxybenzylamine derivatives, processes for preparing them, and their use as intermediates for the preparation of pyrethroid insecticides ICI AUSTRALIA LIMITED (AU) 1982-04-14 EP disclosed
WO-1982001085-A1 BILAYER PHOTOSENSITIVE IMAGING ARTICLE NAPP SYSTEMS INC (US) 1982-04-01 WO disclosed